Anna Altomari
Belluno, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy and safety of oral semaglutide as add-on therapy in poorly controlled type 2 diabetes on background SGLT2 inhibitors: a real-world, multi-center, retrospective, observational study (RYS2).
Journal: Minerva endocrinology
Published: November 27, 2025
Diabetes mellitus in stroke unit: prevalence and outcomes-the Verona acute coronary syndrome and stroke in diabetes outcome (VASD-OUTCOME) study.
Journal: Acta diabetologica
Published: February 15, 2024
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity.
Journal: Acta diabetologica
Published: October 06, 2020
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease.
Journal: Diabetes & metabolism
Published: February 20, 2020
Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: December 23, 2019
Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
Journal: Diabetes & metabolism
Published: May 24, 2019
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes.
Journal: Diabetes & metabolism
Published: February 24, 2019
Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
Journal: Metabolism: clinical and experimental
Published: January 22, 2019
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients.
Journal: European journal of preventive cardiology
Published: July 31, 2018
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report.
Journal: Journal of clinical apheresis
Published: November 02, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026